Literature DB >> 2330208

The reliability of the Pelli-Robson contrast sensitivity chart.

D B Elliott1, K Sanderson, A Conkey.   

Abstract

Normative contrast sensitivity (CS) data were obtained using the commercially available Pelli-Robson chart from the dominant eye of 30 young (mean (+/- SD) age 22.5 +/- 4.3 years) and 42 older (mean (+/- SD) age 70.2+/- 6.7 years) subjects with normal healthy eyes. The majority of young subjects were found to have a CS of 1.80 log units or above. The majority of the older subjects were found to have a CS of 1.65 log units or above. CS results were obtained using both sides (A and B) of the Pelli-Robson chart from 30 (15 young and 15 older) of these subjects. These measurements were repeated under identical conditions, 2 weeks later. There was no significant difference between the results from sides A and B of the chart. The CS scores were shown to be repeatable to within +/- 0.15 log units or +/- 1 step. Therefore a significant change in CS score is +/- 2 steps or 0.30 log units. Slight improvements in reliability could be obtained by more careful permutation of letters on each step and a smaller step size. The restriction against these changes is the ensuing increased chart size.

Mesh:

Year:  1990        PMID: 2330208

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  63 in total

1.  Relation between perceived driving disability and scores of vision screening tests.

Authors:  L J van Rijn; H Wilhelm; M Emesz; R Kaper; S Heine; S Nitsch; G Grabner; H J Völker-Dieben
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

2.  Contrast and glare testing in keratoconus and after penetrating keratoplasty.

Authors:  K Pesudovs; P Schoneveld; R J Seto; D J Coster
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

3.  Effects of yellow filters on visual acuity, contrast sensitivity and reading under conditions of forward light scatter.

Authors:  Frank Eperjesi; Lillian Evangelica Agelis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

4.  Measurement of stray light and glare: comparison of Nyktotest, Mesotest, stray light meter, and computer implemented stray light meter.

Authors:  L J van Rijn; C Nischler; D Gamer; L Franssen; G de Wit; R Kaper; D Vonhoff; G Grabner; H Wilhelm; H J Völker-Dieben; T J T P van den Berg
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

Review 5.  Clinical assessment of two new contrast sensitivity charts.

Authors:  Kavitha Thayaparan; Michael D Crossland; Gary S Rubin
Journal:  Br J Ophthalmol       Date:  2006-12-13       Impact factor: 4.638

6.  FACT contrast sensitivity as a diagnostic tool in glaucoma: FACT contrast sensitivity in glaucoma.

Authors:  Sumru Onal; Ozlem Yenice; Sezen Cakir; Ahmet Temel
Journal:  Int Ophthalmol       Date:  2007-11-14       Impact factor: 2.031

7.  The chinese american eye study: design and methods.

Authors:  Rohit Varma; Chunyi Hsu; Dandan Wang; Mina Torres; Stanley P Azen
Journal:  Ophthalmic Epidemiol       Date:  2013-09-18       Impact factor: 1.648

8.  Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial.

Authors:  Heather E Moss; Weihua Gao; Laura J Balcer; Charlotte E Joslin
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

9.  Vision Impairment and Cognitive Outcomes in Older Adults: The Health ABC Study.

Authors:  Bonnielin K Swenor; Jiangxia Wang; Varshini Varadaraj; Caterina Rosano; Kristine Yaffe; Marilyn Albert; Eleanor M Simonsick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-08-16       Impact factor: 6.053

10.  Multiple Sensory Impairment Is Associated With Increased Risk of Dementia Among Black and White Older Adults.

Authors:  Willa D Brenowitz; Allison R Kaup; Frank R Lin; Kristine Yaffe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-05-16       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.